Table 3.
Questionnaires used in each quantitative study.
| References | Depression | Anxiety | Stress | Emotional distress | Health-related quality of life | Physical functioning | Sexuality | Interactions with medical professionals | Health behavior change | Money | Social support | Work |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beckman et al. (2016) | PHQ-9 | PSS-14 | SF-12 and SAQ | SF-12 | SD | QC | ESSI | |||||
| Brummett et al. (2004) | PSS-10 | |||||||||||
| Bucholz et al. (2014) | PHQ-9 | SF-12 and SAQ | SF-12 | ESSI | ||||||||
| Deasy et al. (2012) | EQ-5D | EQ-5D | EQ-5D and SF-12 | EQ-5D and SF-12 | GOS-E and SF-12 | SF-12 and SD | ||||||
| Dostálová et al. (2017) | IIEF-5 | SAQ | Biological measures of statins, beta blockers, ACEi/ARBs, and antiplatelet therapy | |||||||||
| Dreyer et al. (2015) | EQ-5D | Item in sex questionnaire | SF-12, SAQ, and EQ-5D | EQ-5D and SF-12 | SAQ | SD | ||||||
| Dreyer et al. (2016) | EQ-5D | Item in sex questionnaire | SF-12, SAQ, and EQ-5D | EQ-5D and SF-12 | SAQ | SD | ||||||
| Hinz et al. (2011) | HADS | HADS | ||||||||||
| Joubert et al. (2013) | CDS | SF-12 | SF-12 | SF-12 and CPIEAS | ||||||||
| Koutrolou-Sotiropoulou et al. (2016) | QC | QC | QC | |||||||||
| Lavie and Milani (2006) | SF-36 | SF-36 | KSQ and SF-36 | SF-36 | ||||||||
| Leung Yinko et al. (2014) | HADS | HADS | Unclear | SF-12 and SAQ | SF-12 | ESSI | SD | |||||
| Leung Yinko et al. (2015) | HADS | HADS | FFQ, GSLPAQ, smoking characteristics, and alcohol consumption habits | |||||||||
| Lindau et al. (2014) | PHQ-9 | PSS | SF-12 | SF-12 | Items adapted from prior large-scale interviewer-administered studies of adult sexuality | QC | ||||||
| Lindau et al. (2016) | PHQ-9 | PSS | Items adapted from prior large-scale interviewer-administered studies of adult sexuality | QC | ||||||||
| Lukkarinen and Hentinen (1997) | NHP | NHP | NHP | NHP | SD | |||||||
| Lukkarinen and Hentinen (1998) | NHP | NHP | NHP | NHP | SD | |||||||
| Pelletier et al. (2016a) | HADS | HADS | QC | Unclear | QC | |||||||
| Schweikert et al. (2009) | EQ-5D | EQ-5D | Unclear | EQ-5D and EQ-VAS | EQ-5D | |||||||
| Shah et al. (2014) | PHQ-9 | |||||||||||
| Uusküla (1996) | PARQ | Type A Finnish scale | ||||||||||
| Vaccarino et al. (2014) | BDI-II and SCI | STAI-T/S and visual analog ratings of anxiety | SUDS, PSS, blood pressure, and heart rate | ESSI | ||||||||
| Vaccarino et al. (2016) | BDI-II and SCI | STAI-T/S | SUDS, PSS, blood pressure, and heart rate | |||||||||
| Wong et al. (2013) | MLHFQ | Number of pills taken as prescribed | ||||||||||
| Xu et al. (2015) | EQ-5D | PSS-14, PSS-10, ISLES | SF-12 | SF-12, SAQ, and EQ-5D | EQ-5D and SF-12 | QC | ESSI | QC | ||||
| Xu et al. (2017) | EQ-5D | PSS-14, and ISLES | SAQ | ESSI | QC | |||||||
| Zipori-Beckenstein et al. (1999) | Teichman's questionnaire of trait and state anxiety and QC | QC | QC | QC |
SCI, Structured Clinical Interview for DSM IV; CDS, Cardiac Depression Scale; NHP, Nottingham Health Profile; SUDS, Subjective Units of Distress Scale; PSS, Cohen's Perceived Stress Scale; ISLES, INTERHEART Stressful Life Events Scale; KSQ, Kellner Symptom Questionnaire; SAQ, Seattle Angina Questionnaire; GOS-E, Glasgow Outcome Scale Extended; SF-12, Medical Outcomes Study Short-Form General Health Survey; HADS, Hospital Anxiety and Depression Scale; EQ-5D, EuroQoL 5 Dimensions; BDI-II, Beck Depression Inventory; IIEF-5, International Index of Erectile Function; FFQ, Food Frequency Questionnaire; GSLPAQ, Godin–Shephard Leisure-Time Physical Activity Questionnaire; CPIEAS, Computerized PIE Assessment Schedule; MLHFQ, Minnesota Living HF Questionnaire; QC, questionnaire created for the study; SD, sociodemographic questionnaire.